Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
09/10/2025 22:19
Oct 9 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A: NOVABAY PHARMACEUTICALS INC - DAVID LAZAR RESIGNS AS CEO - SEC FILING Further company coverage: NBY.A (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing